AI assistant
IRADIMED CORP — Director's Dealing 2019
Aug 14, 2019
32324_dirs_2019-08-14_5cb9bdc8-716a-4678-b873-1fcf4b8df3bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2019-08-12
Reporting Person: JOHNSON BRENT (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-12 | Common Stock | A | 1000 | $0.93 | Acquired | 2368 | Direct |
| 2019-08-12 | Common Stock | S | 1000 | $21.27 | Disposed | 1368 | Direct |
| 2019-08-13 | Common Stock | A | 1800 | $0.93 | Acquired | 3168 | Direct |
| 2019-08-13 | Common Stock | S | 1800 | $21.52 | Disposed | 1368 | Direct |
| 2019-08-14 | Common Stock | A | 1000 | $0.93 | Acquired | 2368 | Direct |
| 2019-08-14 | Common Stock | S | 1000 | $21.1 | Disposed | 1368 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-08-12 | Stock Option (Right to Buy) | $0.93 | M | 1000 | Disposed | 2021-12-27 | Common Stock (1000) | Direct |
| 2019-08-13 | Stock Option (Right to Buy) | $0.93 | M | 1800 | Disposed | 2021-12-27 | Common Stock (1800) | Direct |
| 2019-08-14 | Stock Option (Right to Buy) | $0.93 | M | 1000 | Disposed | 2021-12-27 | Common Stock (1000) | Direct |
Footnotes
F1: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019.
F2: This transaction was executed in multiple trades at prices ranging from $21.01 to $22.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $21.00 to $21.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.